Results 21 to 30 of about 3,765 (219)

Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review

Clinical, Cosmetic and Investigational Dermatology, 2023
Prinpat Pinyowiwat, Suthinee Rutnin, Kumutnart Chanprapaph Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Kumutnart Chanprapaph, Division of Dermatology ...
Pinyowiwat P, Rutnin S, Chanprapaph K
doaj  

Sustained Drug Free Remission of Lupus Panniculitis with Methotrexate: A Report From Nepal

Journal of Nepal Medical Association, 2018
Cutaneous manifestations are second most common presenting feature of lupus. Discoid lupus erythematosus is the most common variant amongst all; lupus panniculitis being described in only 2-5% of cases.
Binit Vaidya, Rikesh Baral, Hritu Baral, Shweta Nakarmi   +3 more
doaj   +1 more source

A case of lupus erythematosus panniculitis misdiagnosed as vasculitis

Pifu-xingbing zhenliaoxue zazhi, 2023
We report a case of lupus erythematosus panniculitis misdiagnosed as vasculitis. A 7-year-old boy presented with a 2-year history of erythema and ulceration on the left lower abdomen and depressed skin on the left buttock.
Yuqi TANG, Sai YANG, Yu WANG, Wen ZHENG, Yao ZHOU, Bin YANG   +5 more
doaj   +1 more source

Successful Treatment of Facial Pseudolymphoma With Intravenous Rituximab: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Intravenous rituximab demonstrated significant efficacy in treating a case of refractory cutaneous pseudolymphoma that failed multiple conventional therapies, including corticosteroids, hydroxychloroquine, methotrexate, and biologics. The patient, a 42‐year‐old man, initially developed erythematous, nodular lesions on the face following dental
Behrangi E, Khodakarim N, Amiri S, Rahimi ST, Safarzadeh N, Jafarzadeh A.   +5 more
europepmc   +2 more sources

Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: A systematic review [PDF]

, 2012
Glatiramer acetate and interferon-beta are approved first-line disease-modifying treatments (DMTs) for multiple sclerosis (MS). DMTs can be associated with cutaneous adverse events, which may influence treatment adherence and patient quality of life.
Alava C, Batista J, Bayerl C, Debat Zoguereh D, Devonshire V, Dimov V, Gaudez C, Heinzerling L, Kaiser C, Madray M, Nakamura Y, Navne JE, Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years, Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis, Poulin F, Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis, Rio J, Sanchez-Lopez J, Weinberg JM, Yang CH, Ziegler VR   +20 more
core   +1 more source

Lupus mastitis and antiphospholipid syndrome treated with anticoagulation and immunosuppression: a case report

Journal of Medical Case Reports, 2023
Background Systemic lupus erythematosus is an autoimmune disease that can have cutaneous and systemic manifestations. Lupus panniculitis, also known as lupus mastitis, is a subset of chronic cutaneous lupus erythematosus that involves inflammation of the
Lauren J. He, Laarni C. Quimson, Oluwakemi Onajin, Kimberly C. Trotter   +3 more
doaj   +1 more source

Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects

Anais Brasileiros de Dermatologia, 2023
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusively cutaneous disease or be one of the multiple manifestations of systemic lupus erythematosus.
Everton Carlos Siviero do Vale, Lucas Campos Garcia   +1 more
doaj   +1 more source

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature [PDF]

, 2013
Cutaneous manifestations occur frequently in systemic lupus erythematosus (SLE) and are pathognomonic in subacute-cutaneous lupus erythematosus (SCLE) and chronic cutaneous lupus erythematosus (CCLE).
Hofmann, SC, Isenberg, DA, Leandro, MJ, Morris, SD   +3 more
core   +1 more source

Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study

Advances in Rheumatology, 2019
Objective To evaluate prevalence, clinical manifestations, laboratory abnormalities, treatment and outcome in a multicenter cohort of childhood-onset systemic lupus erythematosus (cSLE) patients with and without panniculitis.
Mônica Verdier, Pedro Anuardo, Natali Weniger Spelling Gormezano, Ricardo Romiti, Lucia Maria Arruda Campos, Nadia Emi Aikawa, Rosa Maria Rodrigues Pereira, Maria Teresa Terreri, Claudia Saad Magalhães, Juliana C. O. A. Ferreira, Marco Felipe Castro Silva, Mariana Ferriani, Ana Paula Sakamoto, Virginia Paes Leme Ferriani, Maraísa Centeville, Juliana Sato, Maria Carolina Santos, Eloisa Bonfá, Clovis Artur Silva   +18 more
doaj   +1 more source

An unusual location of gouty panniculitis: A case report. [PDF]

, 2017
Gouty panniculitis, characterised by the deposition of monosodium urate crystals in subcutaneous tissue, is a rare clinical manifestation of gout. The case of a 67-year-old man is reported, who presented an erythematous nodule on the upper part of the ...
Brunel, C., Demartines, N., Fournier, P., Gié, O., Joliat, G.R., Martin, D.   +5 more
core   +1 more source